Many pharma companies work on the same drug targets in parallel and in secret, which creates enormous duplication and waste of resources.
From monitoring our heart rate and generating renewable energy to keeping astronauts safe in space, a number of novel applications for carbon nanotubes have emerged in recent months, Victoria Hattersley reports.
Is uncorking headed for the dustbin?
The webinar begins by asking the question “Why is the Earth’s surface the temperature it is?”.
With the ever increasing change in the global economic demographics it is time to consider just what impact this has beyond the already accepted increase in healthcare costs.
There are no postcards for the issue of C&I Magazine which you have selected.
Click here to see other postcards from our international correspondents.
US biopharma company Acceleron Pharma, based in Cambridge, MA, has appointed Robert K. Zeldin as CMO.
Abnormal protein homeostasis is implicated in many diseases including cancer.
Drug manufacturers must ensure their drugs are effective and safe. But there is more to consider than clinical trials.
A textbook that is in its sixth edition may reasonably be termed a classic.
As well as preparing for all the different potential Brexit outcomes, including the move of the European Medicines Agency from London to Amsterdam, the European pharma sector is also facing the implementation of the EU Falsified Medicine Directive within the next few months.
UK biotechnology company Albumedix has entered into a collaborative agreement with Novartis.
Obama’s Clean Power Plan has been scrapped. ACE, its replacement, is described as a more ‘affordable’ alternative.
A key aspect in the development of personalised medicine is measurement and analytical technologies. Neil Eisberg highlights the latest analytical instrumentation on show at PittCon 2018 in Orlando, Florida, US.
